Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t there or believe that others are reading or controlling their minds.

Research indicates that the global schizophrenia market was worth $6.7bn in 2009. The global Schizophrenia therapeutics market is forecast to decline with a CAGR of (3.7%) to reach $5.1bn by 2017. This decline in the market is primarily attributed to the release of generics of some of the leading products during the period 2011-2014. The therapeutic market for schizophrenia is expected to decline form 2011 till mid 2014 due to the patent expiry of major marketed drugs such as Zyprexa, Abilify, Seroquel and Geodon. However in the late 2014, the situation is set to improve. There is a huge unmet need in the current market in terms of safety and efficacy. Furthermore, a low treatment seeking rate and low patient compliance rate are likely to act as a barrier to market growth.

The Schizophrenia drug therapy market research report provides insight into the pipeline status of schizophrenia therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the schizophrenia drugs & therapy market.

 



 

View More
TITLE Actions
Global Schizophrenia Drugs Sales Market Report 2021
Published in Apr 2021 | US $ 4000 Onwards | By QYResearch Group

The global Schizophrenia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Drugs market will be able to gain the upper hand as they use the r...

Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) - Drugs in Development, 2021
Published in Mar 2021 | US $ 2000 Onwards | By Global Markets Direct

Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment...

Global Schizophrenia Drugs Market Analysis 2016-2020 and Forecast 2021-2026
Published in Mar 2021 | US $ 2980 Onwards | By 99Strategy

Snapshot The global Schizophrenia Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Ind...

Global Schizophrenia Drugs Market Research Report 2021
Published in Feb 2021 | US $ 2900 Onwards | By QYResearch Group

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Schizophrenia Therapeutics Market Size, Status and Forecast 2021-2027
Published in Jan 2021 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Therapeutics market will be able to gain the upper hand as they use th...

Global Schizophrenia Therapeutics Market Status and Outlook 2021-2026
Published in Jan 2021 | US $ 3160 Onwards | By Multimarket Insight

The report forecast global Schizophrenia Therapeutics market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflatio...

Post-pandemic Era - Global Schizophrenia Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Published in Dec 2020 | US $ 3620 Onwards | By XYZResearch

Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war....

Post-pandemic Era - Global Schizophrenia Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
Published in Dec 2020 | US $ 4860 Onwards | By XYZResearch

Summary This study analysis was given on a worldwide scale, for instance, present and historical Schizophrenia Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaust...

Schizophrenia Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
Published in Dec 2020 | US $ 3000 Onwards | By 99Strategy

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Gl...

Schizophrenia - Pipeline Review, H2 2020
Published in Nov 2020 | US $ 2000 Onwards | By Global Markets Direct

Schizophrenia - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H2 2020, provides an overview of the Schizophrenia (Centra...

Global and Japan Schizophrenia Therapeutics Market Size, Status and Forecast 2020-2026
Published in Nov 2020 | US $ 3900 Onwards | By QYResearch Group

Global Schizophrenia Therapeutics Scope and Market Size Schizophrenia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Therapeutics market will be able to g...

Schizophrenia - Competitive Landscape in 2020
Published in Nov 2020 | US $ 3495 Onwards | By GlobalData

Schizophrenia - Competitive Landscape in 2020 Summary GlobalData’s "Schizophrenia - Competitive Landscape in 2020" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive as...

(Post-pandemic Era) - Global Schizophrenia Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Published in Oct 2020 | US $ 3620 Onwards | By XYZResearch

Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war....

(Post-pandemic Era) - Global Schizophrenia Drugs Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
Published in Oct 2020 | US $ 3650 Onwards | By XYZResearch

Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annual...

(Post-pandemic Era) - Global Schizophrenia Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
Published in Oct 2020 | US $ 4860 Onwards | By XYZResearch

Summary This study analysis was given on a worldwide scale, for instance, present and historical Schizophrenia Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaust...

Obese patients with Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2030
Published in Oct 2020 | US $ 6950 Onwards | By Delve Insight

DelveInsight's "Obese patients with Schizophrenia - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Obese patients with Schizophrenia , historical and forecasted epidemiology as well as the O...

(COVID-19 Version) Global Schizophrenia Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
Published in Oct 2020 | US $ 3000 Onwards | By 99Strategy

Summary The report forecast global Schizophrenia Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of S...

COVID-19 World Schizophrenia Drugs Market Research Report (by Product Type, End-User / Application and Regions / Countries)
Published in Oct 2020 | US $ 2800 Onwards | By HeyReport

Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major r...

Global and China Schizophrenia Treatments Market Size, Status and Forecast 2020-2026
Published in Oct 2020 | US $ 3900 Onwards | By QYResearch Group

Global Schizophrenia Treatments Scope and Market Size Schizophrenia Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Treatments market will be able to gain th...

Schizophrenia - Market Insights, Epidemiology and Market Forecast - 2030
Published in Oct 2020 | US $ 8550 Onwards | By Delve Insight

DelveInsight’s ‘Schizophrenia—Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the Schizophrenia, historical and forecasted epidemiology as well as the Schizophrenia market trends in the United Stat...

We are on:

Need Help?

To know about discount offers contact us at [email protected]